Anzueto, Antonio
Miravitlles, Marc
Funding for this research was provided by:
Boehringer Ingelheim (Not applicable)
Article History
Received: 3 February 2020
Accepted: 26 May 2020
First Online: 29 July 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: AA has received consultant fees from Boehringer Ingelheim, AstraZeneca, GlaxoSmithKline, and Novartis.MM has received speaker fees from AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, Menarini, Rovi, Bial, Sandoz, Zambon, CSL Behring, Grifols, and Novartis; consulting fees from AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Bial, Gebro Pharma, Kamada, CSL Behring, Laboratorios Esteve, Ferrer, Mereo Biopharma, Verona Pharma, TEVA, pH Pharma, Novartis, Sanofi, and Grifols; and research grants from GlaxoSmithKline and Grifols.